SCHEMBL4024620

SCHEMBL4024620

O=[PH2]OCOCO[PH2]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4563364 0.84 — —
SCHEMBL1566989 0.81 — —
SCHEMBL5855547 0.72 — —
SCHEMBL7921744 0.67 — —
Ethylene SCHEMBL248596 0.61 — —
SCHEMBL8935714 0.61 — —
SCHEMBL6887412 0.61 — —
Hydrochloric Acid SCHEMBL9677065 0.59 — —
SCHEMBL3629399 0.59 — —
SCHEMBL3722743 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521439-B2 Glucocorticoid receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2009-04-21 — — US claimed
US-20070027117-A1 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders BISHOP RICHARD D 2007-02-01 — — US claimed
US-7141559-B2 Glucocorticoid receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2006-11-28 — — US claimed
EP-1551860-B1 GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KAROBIO AB (SE) 2006-11-22 — — EP claimed
US-7521439-B2 Glucocorticoid receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2009-04-21 — — US disclosed
US-20070027117-A1 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders BISHOP RICHARD D 2007-02-01 — — US disclosed
US-7141559-B2 Glucocorticoid receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2006-11-28 — — US disclosed
EP-1551860-B1 GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KAROBIO AB (SE) 2006-11-22 — — EP disclosed
EP-1551860-A1 GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2005-07-13 — — EP disclosed
US-20040235810-A1 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders ABBOTT LABORATORIES 2004-11-25 — — US disclosed
WO-2004000869-A1 GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2003-12-31 — — WO disclosed
Send feedback